ANGERS - Six months after condemning, for the first time in France, a laboratory for adverse side effects of Requip, a drug against Parkinson's disease, the lawyer Antoine Béguin drives the point home in a book on indictment Sex and addictions prescription.
I do not question the therapeutic reality of these drugs but the lack of information from their manufacturers and supervisory bodies in respect of patients on the risks of reactions, the author explained to AFP.
His book denounces the negligence of the pharmaceutical companies, deficient controls, the immobility of the Agency Safety of Health Products (AFSSAPS) and recounts the descent into hell of tens of Parkinson's patients who contacted after the first successful lawsuit by a victim of Requip, Didier greaves.
The legal battle of this ancient part in the naval weapons had alerted the public about the side effects of dopamine agonists that can trigger compulsive disorders such as gambling addiction or sexual frenzy.
Didier greaves, a family man with no history, suffering from Parkinson had changed its behavior drastically, after being prescribe Requip from GlaxoSmithKline (GSK). Home, hell took the form of a compulsion to play, to show off and to disguise, he squandered his money, his broken family, made several suicide attempts. Ordered to pay 120,000 euros in compensation, GSK has appealed.
Paranoid delusions, hallucinations, hypersexuality and deviant ... Advocate Angevin reports in his book dozens of other dramatic cases that have broken families, with divorce, suicide and sexual abuse of minors
It is this avalanche of testimony received I decided to write this book. I understood that Didier J. was far from an isolated case. Experts estimate between 15 and 20% the number of patients suffering from these effects, he says.
He said there was a constant offset between the state of scientific knowledge about the side effects of drugs and their inclusion in the records and the Vidal, the bible of doctors.
In line with Irene Frachon, the lung of Brest has succeeded in launching a book by the case of the Mediator, the lawyer argues for the establishment of a true pharmacovigilance, disinterested and independent laboratories.